Evropská unie -
čeština -
EMA (European Medicines Agency)
jardiance
boehringer ingelheim international gmbh - empagliflozin - diabetes mellitus, type 2; heart failure; renal insufficiency, chronic - léky užívané při diabetu - type 2 diabetes mellitusjardiance is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered in addition to other medicinal products for the treatment of diabetesfor study results with respect to combinations of therapies, effects on glycaemic control, and cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 a 5. of the annex. heart failurejardiance is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseasejardiance is indicated in adults for the treatment of chronic kidney disease.
Česká republika -
čeština -
SUKL (Státní ústav pro kontrolu léčiv)
empagliflozin polpharma 10mg potahovaná tableta
zaklady farmaceutyczne polpharma sa, starogard gdański array - 19333 empagliflozin - potahovaná tableta - 10mg - empagliflozin
Česká republika -
čeština -
SUKL (Státní ústav pro kontrolu léčiv)
empagliflozin polpharma 25mg potahovaná tableta
zaklady farmaceutyczne polpharma sa, starogard gdański array - 19333 empagliflozin - potahovaná tableta - 25mg - empagliflozin
Česká republika -
čeština -
SUKL (Státní ústav pro kontrolu léčiv)
empelic 10mg potahovaná tableta
zaklady farmaceutyczne polpharma sa, starogard gdański array - 19333 empagliflozin - potahovaná tableta - 10mg - empagliflozin
Česká republika -
čeština -
SUKL (Státní ústav pro kontrolu léčiv)
empelic 25mg potahovaná tableta
zaklady farmaceutyczne polpharma sa, starogard gdański array - 19333 empagliflozin - potahovaná tableta - 25mg - empagliflozin